NDC 51662-1201
Adenosine Injection, 6mg/2mL (3mg/mL) Vial
Adenosine Injection, 6mg/2ml (3mg/ml) Vial
Adenosine Injection, 6mg/2mL (3mg/mL) Vial is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Hf Acquisition Co. Llc, Dba Health First. The primary component is Adenosine.
| Product ID | 51662-1201_70fb0ea7-3896-b34d-e053-2a95a90a3409 |
| NDC | 51662-1201 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Adenosine Injection, 6mg/2mL (3mg/mL) Vial |
| Generic Name | Adenosine Injection, 6mg/2ml (3mg/ml) Vial |
| Dosage Form | Injection, Solution |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2018-07-14 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA078076 |
| Labeler Name | HF Acquisition Co. LLC, DBA Health First |
| Substance Name | ADENOSINE |
| Active Ingredient Strength | 3 mg/mL |
| Pharm Classes | Adenosine Receptor Agonist [EPC],Adenosine Receptor Agonists [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2019-12-31 |